| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 76.6 | ¤1,146,052 | US |
| JNJ | Johnson & Johnson | 51.2 | ¤623,711 | US |
| MRK | Merck & Co., Inc. | 54.0 | ¤308,900 | US |
| AZN.GB | AstraZeneca PLC | 60.0 | ¤266,812 | GB |
| NOVO.B.DK | Novo Nordisk A/S Class B | 75.0 | ¤218,124 | DK |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 326030.KR | SK Biopharmaceuticals Co., Ltd. | 79.9 | ¤4,305 | KR |
| YPSN.CH | Ypsomed Holding AG | 69.3 | ¤5,648 | CH |
| ALK.B.DK | ALK-abello A/S Class B | 74.2 | ¤8,208 | DK |
| 4151.JP | Kyowa Kirin Co., Ltd. | 66.8 | ¤8,551 | JP |
| HALO | Halozyme Therapeutics, Inc. | 72.9 | ¤9,325 | US |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| NOVO.B.DK | Novo Nordisk A/S Class B | 75.0 | 38 | DK |
| AMGN | Amgen Inc. | 61.8 | 31 | US |
| ISRG | Intuitive Surgical, Inc. | 72.6 | 27 | US |
| RMD | ResMed Inc. | 67.4 | 25 | US |
| JNJ | Johnson & Johnson | 51.2 | 24 | US |
| LLY | Eli Lilly and Company | 76.6 | 23 | US |
| 4507.JP | Shionogi & Co., Ltd. | 68.4 | 22 | JP |
| BMY | Bristol-Myers Squibb Company | 61.9 | 22 | US |
| 4519.JP | Chugai Pharmaceutical Co., Ltd. | 66.0 | 21 | JP |
| 7741.JP | HOYA CORPORATION | 68.9 | 21 | JP |
| Average Market Cap | ¤87,224 |
| Median Market Cap | ¤28,176 |
| Avg. 3 Mo. Dollar Vol. | ¤365,111,158 |
| Avg. 3 Mo. Trading Vol. | 2,757,302 |
| Last Rebalance Date | 03/23/2026 |
| Companies Replaced | 11 |
| Biggest Industry Increase | Medical Specialties |
| Biggest Industry Decrease | Pharmaceuticals: Major |
| Trailing P/E Ratio (12 Mo.) | 25.7 |
| Forward P/E Ratio (12 Mo.) | 18.7 |
| Price/Book Ratio | 6.4 |
| Avg. Revenue Chg. - 3 Yr | 40.9% |
| Avg. Op. Income Chg. - 3 Yr. | 92.0% |
| Avg. EPS Growth - 3 Yr. | 25.3% |
| Avg. EPS Growth - 1 Yr. | 16.7% |
| Avg. Operating Margin | 25.9% |
| Avg. LT Debt to Total Capital | 25.9% |
| Avg. Return on Equity | 23.0% |
| Dividend Yield | 0.4% |
| Developed Markets (ex-Australia) Health Care Index | 67.14 |
| United States Of America | 58.0% |
| Japan | 14.0% |
| Korea, Republic Of | 6.0% |
| Denmark | 4.0% |
| United Kingdom | 4.0% |
| Israel | 2.0% |
| Finland | 2.0% |
| France | 2.0% |
| Belgium | 2.0% |
| Switzerland | 2.0% |
| Netherlands | 2.0% |
| New Zealand | 2.0% |
